ArticleJournal for immunotherapy of cancer2020

Oxazaphosphorines combined with immune checkpoint blockers: dose-dependent tuning between immune and cytotoxic effects.

Julia Delahousse et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.